SCHEMBL1999053

SCHEMBL1999053

Cc1ccc2nc(-c3ccc(C=Cc4ccc([N+](=O)[O-])cc4OC(C)O[Si](C)(C)C(C)(C)C)cc3)cn2c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 13/20 0.46
NPC1 O15118 12/20 0.46
ALDH1A1 P00352 12/20 0.46
SMN1; SMN2 Q16637 10/20 0.46
LMNA P02545 4/20 0.46
GAA P10253 3/20 0.46
POLB P06746 1/20 0.46
STAT3 P40763 1/20 0.46
CASP3 P42574 1/20 0.46
SENP7 Q9BQF6 1/20 0.46
SENP6 Q9GZR1 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
MAPT P10636 8/20 0.42
KMT2A Q03164 5/20 0.42
MEN1 O00255 3/20 0.42
APP P05067 3/20 0.40
KDM4E B2RXH2 10/20 0.37
PAX8 Q06710 2/20 0.37
MITF O75030 1/20 0.37
KDM5A P29375 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1999050 0.84 RAB9A (0.46) RAB9ANPC1ALDH1A1SMN1; SMN2LMNA
SCHEMBL1999051 0.84 RAB9A (0.46) RAB9ANPC1ALDH1A1SMN1; SMN2LMNA
SCHEMBL2194990 0.83 RAB9A (0.58) RAB9ANPC1ALDH1A1SMN1; SMN2LMNA
SCHEMBL2194986 0.83 RAB9A (0.58) RAB9ANPC1ALDH1A1SMN1; SMN2LMNA
SCHEMBL1999048 0.81 RAB9A (0.44) RAB9ANPC1ALDH1A1SMN1; SMN2LMNA
SCHEMBL1984672 0.80 RAB9A (0.52) RAB9ANPC1ALDH1A1SMN1; SMN2LMNA
SCHEMBL1984676 0.80 RAB9A (0.52) RAB9ANPC1ALDH1A1SMN1; SMN2LMNA
SCHEMBL12422082 0.79 RAB9A (0.61) RAB9ANPC1ALDH1A1SMN1; SMN2LMNA
SCHEMBL12422151 0.79 RAB9A (0.51) RAB9ANPC1ALDH1A1SMN1; SMN2LMNA
SCHEMBL1985017 0.79 RAB9A (0.51) RAB9ANPC1ALDH1A1SMN1; SMN2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2338059-B1 Ligands for aggregated tau molecules WISTA LAB LTD (SG) 2015-04-08 EP disclosed
US-8895313-B2 Ligands for aggregated tau molecules WISTA LABORATORIES LTD. (SG) 2014-11-25 US disclosed
US-20110171739-A1 LIGANDS FOR AGGREGATED TAU MOLECULES WISTA LABORATORIES LTD. 2011-07-14 US disclosed
EP-2338059-A1 LIGANDS FOR AGGREGATED TAU MOLECULES Wista Laboratories Ltd. (SG) 2011-06-29 EP disclosed
WO-2010034982-A1 LIGANDS FOR AGGREGATED TAU MOLECULES WISTA LABORATORIES LTD. (SG) 2010-04-01 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110171739-A1 LIGANDS FOR AGGREGATED TAU MOLECULES MAPT, PRNP, MAP4 RAB9A 2622/4885NPC1 1265/4885ALDH1A1 2058/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.